| Code | 04494 | ||||||||||
| MA number | 56/0071/11-S | ||||||||||
| Product Form: | gra ent 30x9 mg (vre.Al/PE/PES) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Dr. Falk Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | sachet PE/Al/PES | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 03.02.2011 |
| SPC: |
SPC_Budenofalk_ 9 mg_12_2022.pdf
|
| PIL: |
PIL_Budenofalk_ 9 mg_12_2022.pdf
|
| Safety feature | Yes |
| Data update: | 20.08.2019 |
